Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis

By Papp Kim   Ho Vincent   Langley Richard   Lynde Charles   Poulin Yves   Shear Neil   Toole John   Zip Catherine  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 26-32

Springer Publishing Company

Access to resources Recommend Favorite

Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan

By Igarashi Atsuyuki   Kuwabara Hiroyo   Fahrbach Kyle   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 351-355

Informa Healthcare

Access to resources Recommend Favorite

Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis

By Gattu Shilpa   Pang Mei-Lin   Pugashetti Rupa   Malick Farah   Hong Judith   Bowers Elyn   Levatter Jeffrey I.   Koo John  

Journal of Dermatological Treatment, Vol. 21, Iss. 1, 2010-01 ,pp. : 54-60

Informa Healthcare

Access to resources Recommend Favorite

Efalizumab: Integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis

By Lynde Charles  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 1, 2005-12 ,pp. : 1-3

Springer Publishing Company

Access to resources Recommend Favorite

An update on drug–drug interactions with biologics for the treatment of moderate-to-severe psoriasis

By Gupta Rishu   Levin Ethan   Wu Jashin J.   Koo John   Liao Wilson  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 87-89

Informa Healthcare

Access to resources Recommend Favorite